Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Surg Oncol Clin N Am. 2008 Apr;17(2):257-77, vii. doi: 10.1016/j.soc.2007.12.001.

Genomics and proteomics in predicting cancer outcomes.

Author information

  • 1Vanderbilt University School of Medicine, 597 PRB, 2220 Pierce Avenue, Nashville, TN 37232, USA.

Abstract

Sequencing of the human genome and the acquisition of genomic data combined with advances in genomic and proteomic technologies have fueled a revolution in understanding disease. The combination of genomics and proteomics has provided a unique opportunity to diagnose, classify, and detect malignant disease, to better understand and define the behavior of specific tumors, and to provide direct and targeted therapy. Nevertheless, challenges remain, including integration and standardization of techniques and validation against accepted clinical and pathologic parameters. This article provides a summary of technologies, potential clinical applications, and challenges.

PMID:
18375352
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk